Dilaudid-HP
- Generic Name: hydromorphone hydrochloride injection
- Brand Name: Dilaudid-HP
- Drug Class: Opioid Analgesics
Dilaudid-HP(Hydromorphone Hydrochloride Injection) side effects drug center
Dilaudid-HP Side Effects Center
Dilaudid-HP (hydromorphone hydrochloride) Injection is a narcotic pain reliever used to treat moderate to severe pain. Dilaudid-HP is available in generic form. Common side effects of Dilaudid-HP include:
- nausea,
- vomiting,
- constipation,
- diarrhea,
- stomach pain,
- lightheadedness,
- dizziness,
- drowsiness,
- blurred vision,
- double vision,
- flushing (warmth, redness, tingly feeling),
- dry mouth,
- sweating,
- itching,
- sleep problems (insomnia),
- strange dreams, or
- injection site reactions (pain, redness, or swelling).
Tell your doctor if you have unlikely but serious side effects of Dilaudid-HP including:
- severe stomach or abdominal pain,
- fainting,
- mental/mood changes (such as agitation, hallucinations, confusion),
- seizures,
- changes in the amount of urine, or
- difficulty urinating.
Dosage of Dilaudid-HP is individualized and determined based on the patient's age, general condition, medical status, type and severity of pain, risk factors for abuse or addiction, and other factors. Dilaudid-HP may interact with other narcotic pain medications, sedatives, tranquilizers, muscle relaxers, medicines that make you sleepy or slow breathing, pentazocine, nalbuphine, butorphanol, or buprenorphine. Tell your doctor all medications you use. During pregnancy, Dilaudid-HP should be used only when prescribed. Using it near the expected delivery date is not recommended because of possible harm to the fetus. Infants born to mothers who have used this medication may have breathing problems or withdrawal symptoms such as irritability, abnormal/persistent crying, vomiting, or diarrhea. Tell your doctor if you notice these symptoms in your newborn. This medication may pass into breast milk. Consult your doctor before breastfeeding. Dilaudid-HP may be habit-forming. Do not stop using Dilaudid-HP suddenly, or you could have withdrawal symptoms.
Our Dilaudid-HP (hydromorphone hydrochloride) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Dilaudid-HP Consumer Information
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Opioid medicine can slow or stop your breathing, and death may occur. A person caring for you should seek emergency medical attention if you have slow breathing with long pauses, blue colored lips, or if you are hard to wake up.
Call your doctor at once if you have:
- noisy breathing, sighing, shallow breathing, breathing that stops during sleep;
- severe drowsiness;
- a light-headed feeling, like you might pass out; or
- low cortisol levels--nausea, vomiting, loss of appetite, dizziness, worsening tiredness or weakness.
Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.
Serious breathing problems may be more likely in older adults and people who are debilitated or have wasting syndrome or chronic breathing disorders.
Common side effects may include:
- constipation, nausea, vomiting;
- dizziness, drowsiness;
- flushing (warmth, redness, or tingly feeling);
- sweating, itching;
- dry mouth; or
- mood changes.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Dilaudid-HP (Hydromorphone Hydrochloride Injection)
Dilaudid-HP Professional Information
SIDE EFFECTS
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
Serious adverse reactions associated with DILAUDID INJECTION and DILAUDID-HP INJECTION include respiratory depression and apnea and, to a lesser degree, circulatory depression, respiratory arrest, shock, and cardiac arrest.
The following serious adverse reactions described elsewhere in the labeling include:
- Respiratory depression and secondary effects on intracranial pressure [see WARNINGS AND PRECAUTIONS]
- Hypotension [see WARNINGS AND PRECAUTIONS]
- Gastrointestinal effects and effects in sphincter of Oddi [see WARNINGS AND PRECAUTIONS]
- Drug abuse, addiction, and dependence [see Drug Abuse And Dependence]
- Effects on the ability to drive and operate machinery [see WARNINGS AND PRECAUTIONS]
The most common adverse effects are lightheadedness, dizziness, sedation, nausea, vomiting, sweating, flushing, dysphoria, euphoria, dry mouth, and pruritus. These effects seem to be more prominent in ambulatory patients and in those not experiencing severe pain.
Less Frequently Observed Adverse Reactions
Cardiac disorders: tachycardia, bradycardia, palpitations
Eye disorders: vision blurred, diplopia, miosis, visual impairment
Gastrointestinal disorders: constipation, ileus, diarrhea, abdominal pain
General disorders and administration site conditions: weakness, feeling abnormal, chills, injection site urticaria
Hepatobiliary disorders: biliary colic
Metabolism and nutrition disorders: decreased appetite
Musculoskeletal and connective tissue disorders: muscle rigidity
Nervous system disorders: headache, tremor, paraesthesia, nystagmus, increased intracranial pressure, syncope, taste alteration, involuntary muscle contractions, presyncope
Psychiatric disorders: agitation, mood altered, nervousness, anxiety, depression, hallucination, disorientation, insomnia, abnormal dreams
Renal and urinary disorders: urinary retention, urinary hesitation, antidiuretic effects
Respiratory, thoracic, and mediastinal disorders: bronchospasm, laryngospasm
Skin and subcutaneous tissue disorders: injection site pain, urticaria, rash, hyperhidrosis
Vascular disorders: flushing, hypotension, hypertension
Postmarketing Experience
The following adverse reactions have been identified during post-approval use of hydromorphone. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure: anaphylactic reactions, confusional state, convulsions, drowsiness, dyskinesia, dyspnea, erectile dysfunction, fatigue, hepatic enzymes increased, hyperalgesia, hypersensitivity reaction, injection site reactions, lethargy, myoclonus, oropharyngeal swelling, peripheral edema, and somnolence.
Read the entire FDA prescribing information for Dilaudid-HP (Hydromorphone Hydrochloride Injection)
&Copy; Dilaudid-HP Patient Information is supplied by Cerner Multum, Inc. and Dilaudid-HP Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.